This inventor holds 1 USPTO granted patent. Top assignee: University of Warsaw. Active years: 2019.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2019
Title: Beata Wileńska: Innovator in Peptidomimetics
Introduction
Beata Wileńska is a prominent inventor based in Piastów, Poland. She has made significant contributions to the field of medicinal chemistry, particularly through her innovative work on peptidomimetics. Her research focuses on developing novel compounds with therapeutic applications, showcasing her dedication to advancing medical science.
Latest Patents
Wileńska holds a patent for "Peptidomimetics with antiangiogenic activity." This patent discloses novel peptidomimetics that exhibit antiangiogenic properties and their potential uses in treating various conditions, including neoplasms and chronic inflammation. The applications of her invention extend to diseases such as rheumatoid arthritis, colitis, eczema, diabetes, age-related macular degeneration (ARMD), nephropathy, and neuropathy. The innovative compounds can be administered through intravenous infusions, injections, or implants that release the active ingredient.
Career Highlights
Beata Wileńska is affiliated with the University of Warsaw, where she continues her research and development efforts. Her work has garnered attention for its potential impact on treating serious health conditions, reflecting her commitment to improving patient outcomes through scientific innovation.
Collaborations
Wileńska collaborates with notable colleagues, including Aleksandra Misicka-Kęsik and Dagmara Tymecka. These partnerships enhance her research capabilities and contribute to the advancement of their shared scientific goals.
Conclusion
Beata Wileńska is a trailblazer in the field of peptidomimetics, with a focus on developing innovative treatments for various medical conditions. Her contributions to science and medicine are invaluable, and her work continues to inspire future research in the field.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
